Medical Marketing Economics
Acquisition in 2021
Medical Marketing Economics (MME) specializes in providing value-based strategies and market research services tailored for life sciences organizations. The company focuses on helping clients determine and communicate the optimal market value of their innovations. MME's offerings include strategy evaluation and development, advisory boards, payer panels, and customized market research. Additionally, the firm provides tactical pricing services and guidance on pricing and reimbursement, ensuring that clients can effectively identify, frame, communicate, and capture the value of their products in a competitive landscape. Through its intellectual curiosity and commitment to solving complex challenges, MME delivers insights that empower organizations to refine their marketing strategies and enhance their market presence.
Wincere
Acquisition in 2016
Wincere is a prominent clinical data management and research services provider based in Silicon Valley, California. Specializing in clinical and statistical programming solutions, Wincere supports the clinical research and development needs of emerging biopharma companies. The company offers comprehensive services across all phases of clinical trials, utilizing its patent-pending, mobile, and cloud-enabled technologies to enhance clinical trial startup, conduct, and submission activities. Wincere positions itself as a resource for businesses seeking expert guidance on various business and technology options, thereby facilitating informed decision-making in the pharmaceutical sector.
Encima Group
Acquisition in 2016
Encima Group, headquartered in Newark, Delaware, specializes in providing business analytics, big data, and digital marketing services. They assist clients in developing comprehensive, longitudinal customer journey analytics to enhance overall customer experience through innovative solutions and strategic consulting across digital and multi-channel platforms.
Skura is an international company established in 1996, specializing in mobile sales enablement solutions, particularly for the life sciences and pharmaceutical sectors. Its flagship platform, SKURA SFX, is designed to enhance the productivity of sales teams by offering reliable and scalable tools for planning, organizing, presenting, and tracking mobile content and applications. This platform provides valuable predictive analytics, allowing sales and marketing executives to effectively engage with healthcare providers across various channels and devices. With over 30,000 sales representatives utilizing its solutions, Skura supports more than 100 brands in 34 countries, helping companies improve key performance indicators such as revenue growth, market share, and support costs through innovative technology.
MedCases
Acquisition in 2006
MedCases focuses on the development of medical e-learning solutions for the pharmaceutical and biotechnology industry. MedCases offers ADHD Point of Care CME Program that focuses on educating physicians on the diagnosis and treatment of attention-deficit hyperactivity disorder. MedCases was acquired by Indegene Lifesystems in November 2006. MedCases was founded in 1971 and is based in Princeton, New Jersey.